ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 108165 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 108165; 2) Community: the network communities that were significantly associated with the response to NSC 108165; 3) Molecule: the relationships between components within communities and NSC 108165; 4) MDR: the compounds that were significantly associated with the NSC 108165.

NSC Compound Enrichment Correlation
NSC 686130 Acetamide, N-[6'-(diethylamino)-3-oxospiro-[isobenzofuran-1(3H),9'-[9H]xanthen]-2'-yl]-N-phenyl- 0.0178844438004194 0.38269683
NSC 703315 Null 0.0178844438004194 0.37105275
NSC 703318 Null 0.0178844438004194 0.29678675
NSC 716281 Null 0.0178844438004194 -0.51197237
NSC 733164 Null 0.0178844438004194 0.44758025
NSC 736153 Null 0.0178844438004194 0.31594741
NSC 743432 2-{5-[4-(5-{4-[6-morpholino-1H-benzo[d]imidazole-2-yl]phenoxy}pentyl)piperazino]pentyl}-2,3-dihydro-1H-benzo[de]isoquinoline-1,3-dione 0.0178844438004194 0.36091643
NSC 758965 CEPHARANTHINE 0.0178844438004194 0.61969667
NSC 115928 Benzonitrile, 3-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)-, monoethanesulfonate (9CI) 0.0183522248172065 0.12461628
NSC 697192 Decanediamide, N,N'-bis[2-(2-hydroxy-1-naphthalenyl)- 5-(3,4-dihydroxyphenyl)methylene]-4-oxo- 3-thiazolidinyl]- 0.0183522248172065 0.099071732
Total:99  Current:46    [First] [Prev] [Next] [Last]